Biblio

Author Title Type [ Year(Desc)]
Filters: Author is Yao, Yu  [Clear All Filters]
2013
Mills JA, Wang K, Paluru P, Ying L, Lu L, Galvão AM, Xu D, Yao Y, Sullivan SK, Sullivan LM, et al. Clonal genetic and hematopoietic heterogeneity among human induced pluripotent stem cell lines. Blood. 2013.
2015
Byrska-Bishop M, VanDorn D, Campbell AE, Betensky M, Arca PR, Yao Y, Gadue P, Costa FF, Nemiroff RL, Blobel GA, et al. Pluripotent stem cells reveal erythroid-specific activities of the GATA1 N-terminus. J Clin Invest. 2015.
2019
Métais J-Y, Doerfler PA, Mayuranathan T, Bauer DE, Fowler SC, Hsieh MM, Katta V, Keriwala S, Lazzarotto CR, Luk K, et al. Genome editing of HBG1 and HBG2 to induce fetal hemoglobin. Blood Adv. 2019;3(21):3379-3392.
Cui J, Zhang Q, Song Q, Wang H, Dmitriev P, Sun M, Cao X, Wang Y, Guo L, Indig I, et al. Targeting Hypoxia Downstream Signaling Protein, CAIX, for CAR-T Cell Therapy against Glioblastoma. Neuro Oncol. 2019.
2022
Sherpa D, Mueller J, Karayel Ö, Xu P, Yao Y, Chrustowicz J, Gottemukkala KV, Baumann C, Gross A, Czarnecki O, et al. Modular UBE2H-CTLH E2-E3 complexes regulate erythroid maturation. Elife. 2022;11.
Li W, Yang Y, Zhang X, Lin Y, Li H, Yao Y, Mu D. The preliminary study of exosomes derived from thymosin beta 4-treated adipose-derived stem cells in fat grafting. Genes Genomics. 2022.
Bhoopalan SVelan, Yen JS, Mayuranathan T, Mayberry KD, Yao Y, Osuna MAngeles Li, Jang Y, Liyange JSs, Blanc L, Ellis SR, et al. An RPS19-edited model for Diamond-Blackfan anemia reveals TP53-dependent impairment of hematopoietic stem cell activity. JCI Insight. 2022.
2023
Wang J, Zheng X, Fu X, Jiang A, Yao Y, He W. A dual-targeting supramolecular self-assembly peptide against pulmonary metastasis of melanoma. Theranostics. 2023;13(11):3844-3855.
Mayuranathan T, Newby GA, Feng R, Yao Y, Mayberry KD, Lazzarotto CR, Li Y, Levine RM, Nimmagadda N, Dempsey E, et al. Potent and uniform fetal hemoglobin induction via base editing. Nat Genet. 2023.
2024
Jiang A, Zheng X, Yan S, Yan J, Yao Y, He W. Advancing the Boundaries of Immunotherapy in Lung Adenocarcinoma with Idiopathic Pulmonary Fibrosis by a Biomimetic Proteinoid Enabling Selective Endocytosis. ACS Nano. 2024.